In the HepG2 hepatocellular carcinoma cell line, which frequently serves as a hepatocyte model, leptin increased the expression of PCSK9, causing reduced LDL-R levels and impaired LDL uptake [80]. Here, PCSK9 is linked to hepatocellular carcinoma.